About Lungpacer
Lungpacer is a company based in Vancouver (Canada) founded in 2009. Lungpacer has raised $121.38 million across 8 funding rounds from investors including Canadian Institutes of Health Research and Military Health. Lungpacer offers products and services including AeroPace System and AeroNova System. Lungpacer operates in a competitive market with competitors including Belluscura, hemovent, ALung, OneBreath and Securisyn, among others.
- Headquarter Vancouver, Canada
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Lungpacer Medical, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$121.38 M (USD)
in 8 rounds
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Lungpacer
Lungpacer offers a comprehensive portfolio of products and services, including AeroPace System and AeroNova System.
Stimulates diaphragm to aid weaning from mechanical ventilation.
Used for clinical investigations in breathing support technologies.
People of Lungpacer
Unlock access to complete
Unlock access to complete
Funding Insights of Lungpacer
Lungpacer has successfully raised a total of $121.38M across 8 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Lungpacer
Lungpacer has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Canadian Institutes of Health Research and Military Health.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Administers health care and support for military personnel and operations.
|
Locked | Locked | Locked | |
|
Health research projects in Canada are funded and supported.
|
Locked | Locked | Locked |
Investor details for Lungpacer
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Lungpacer
Investment portfolio details for Lungpacer
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Lungpacer
Detailed financials for Lungpacer
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lungpacer Comparisons
Peer comparison for Lungpacer
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Lungpacer
Lungpacer operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Belluscura, hemovent, ALung, OneBreath and Securisyn, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of medical devices for laparoscopic procedures
|
|
| Locked | Locked | Locked |
Equipment for extracorporeal life support and CO2 removal is developed.
|
|
| Locked | Locked | Locked |
Extracorporeal CO2 removal systems are developed to supplement mechanical ventilation.
|
|
| Locked | Locked | Locked |
Portable mechanical ventilators for intensive care patients are developed.
|
|
| Locked | Locked | Locked |
Endotracheal tube stabilization systems for ventilated patients are developed.
|
Detailed competitors of Lungpacer
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lungpacer
Complete news archive for Lungpacer
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lungpacer
Lungpacer was founded in 2009 and raised its 1st funding round 4 years after it was founded.
Lungpacer is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.
Doug Evans is the current CEO of Lungpacer.
Lungpacer is a funded company, having raised a total of $121.38M across 8 funding rounds to date.
Lungpacer was founded in 2009 in Vancouver, Canada, within the medical device sector focused on respiratory health. A neurostimulation system is provided by the company, utilizing minimally invasive transvascular technology to activate the diaphragm. Electrodes are inserted intravenously to enable rhythmic stimulation, restoring negative pressure ventilation. Pacing therapy is applied to prevent or reverse diaphragm muscle atrophy and sustain endurance. Operations center on this technology for clinical applications.
Lungpacer's top competitors include Belluscura, hemovent and ALung.
Lungpacer offers AeroPace System and AeroNova System.
Lungpacer has 2 investors. Key investors include Canadian Institutes of Health Research, and Military Health.